Difference between revisions of "Main Page"
m |
|||
Line 17: | Line 17: | ||
!colspan="4" align="center" style="color:white; font-size:200%; background-color:#696969"| Quick links to chemotherapy regimens | !colspan="4" align="center" style="color:white; font-size:200%; background-color:#696969"| Quick links to chemotherapy regimens | ||
|- | |- | ||
− | !colspan="4" align="center" style="color:white; font-size:150%; background-color:#00008B"| '''Solid | + | !colspan="4" align="center" style="color:white; font-size:150%; background-color:#00008B"| '''Solid Tumors''' |
|- | |- | ||
|colspan="4" style="background-color:#93cdff"|Site-agnostic | |colspan="4" style="background-color:#93cdff"|Site-agnostic | ||
Line 73: | Line 73: | ||
|style="background-color:#F0F8FF"| | |style="background-color:#F0F8FF"| | ||
|- | |- | ||
− | + | !colspan="4" align="center" style="color:white; font-size:150%; background-color:#FF0D00"| '''Malignant Hematology''' | |
+ | |- | ||
+ | |colspan="4" style="background-color:#ff9e99"| Acute leukemias | ||
|- | |- | ||
|style="background-color:#FFF0F5"|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] | |style="background-color:#FFF0F5"|[[Acute myeloid leukemia | Acute myeloid leukemia (AML)]] | ||
Line 85: | Line 87: | ||
|style="background-color:#FFF0F5"| | |style="background-color:#FFF0F5"| | ||
|- | |- | ||
− | |colspan="4 | + | |colspan="4" style="background-color:#ff9e99"| Myeloproliferative neoplasms and myelodysplastic syndromes |
|- | |- | ||
|style="background-color:#FFF0F5"|[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] | |style="background-color:#FFF0F5"|[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]] | ||
Line 97: | Line 99: | ||
|style="background-color:#FFF0F5"|[[Systemic mastocytosis]] | |style="background-color:#FFF0F5"|[[Systemic mastocytosis]] | ||
|- | |- | ||
− | |colspan="4 | + | |colspan="4" style="background-color:#ff9e99"| Mature B-, T-, and NK-cell neoplasms |
|- | |- | ||
|style="background-color:#FFF0F5"|[[Adult T-cell leukemia-lymphoma|Adult T-cell leukemia-lymphoma (ATLL)]] | |style="background-color:#FFF0F5"|[[Adult T-cell leukemia-lymphoma|Adult T-cell leukemia-lymphoma (ATLL)]] | ||
Line 134: | Line 136: | ||
|style="background-color:#FFF0F5"| | |style="background-color:#FFF0F5"| | ||
|- | |- | ||
− | |colspan="4" align="center" style="color:white; font-size:150%; background-color:#228B22"| '''Other | + | |colspan="4" align="center" style="color:white; font-size:150%; background-color:#228B22"| '''Other Hematology''' |
|- | |- | ||
|style="background-color:#F0FFF0"|[[Aplastic anemia]] | |style="background-color:#F0FFF0"|[[Aplastic anemia]] |
Revision as of 17:42, 13 July 2017
HemOnc.org - A Free Hematology/Oncology Reference
4,428 regimens on HemOnc.org |
6,546 variants on HemOnc.org
|
Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.
Desktop Version of HemOnc.org | Mobile (phone/tablet) Version of HemOnc.org
How to add a HemOnc.org shortcut to your mobile device's home screen
Hematology Oncology Fellowship Programs Directory
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:
- Creating a database of chemotherapy agents and other medications.
- Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Establishing homepages for ongoing clinical trials that contain information and sites of participation
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.